- Ghana has so far recorded 80,253 cases of the virus and 577 deaths
- The country currently has 6,658 active cases of infection, according to the latest update from the Ghana Health Service
- Meanwhile, the first batch of COVID-19 vaccines are expected into the country on Monday, February 22
Our manifesto: This is what YEN.com.gh believes in
Over 60 health workers at the Savelugu Municipal Hospital in the Northern Region tested positive for COVID-19, YEN.com.gh has gathered.
This was after mass testing of staff at the facility following the disturbing increase in recorded cases in the municipality.
YEN.com.gh understands that there are more samples at the laboratory yet to be tested.
Still on COVID-19, Information Minister-designate, Kojo Oppong Nkrumah disclosed that Ghana would take delivery of its first batch of the COVID-19 vaccines on Monday, February 22, 2021—that’s later today hopefully.
The disclosure was made over the weekend at the Conference and Donor Presentation for the Sustainable Development of Yendi Municipal Hospital.
The country is one of the 145 countries of the UN-led COVAX Facility earmarked to take delivery of 2.4 million doses of the AstraZeneca vaccine licensed to the Serum Institute of India (AZ/SII).
In a related development, YEN.com.gh earlier reported that Ghana also signed on to a consignment of the Russian Sputnik V Covid-19 vaccine.
This emergency authorization was captured in a press statement by the Russian Government which states the Ghana government had “granted an emergency authorization” of the vaccine, Reuters News Agency reported.
Over 200 million dollars is being spent to procure the vaccines, the Ghana Health Service (GHS) revealed.
In the meantime though, herbal medicine, Cryptolepis sanguinolenta, was approved for a clinical trial in Ghana for the treatment of COVID-19.
Known locally as ‘Nibima’, Cryptolepis sanguinolenta's approval for the trial was announced on Monday, February 1, 2021, by the Food and Drugs Authority (FDA).
The herbal medicine developed by the School of Public Health at the Kwame Nkrumah University of Science and Technology (KNUST) was submitted to the FDA for the clinical trial in September 2020 and approval was granted in January 2021.
Ghana has had 80,253 cases of the virus and 577 deaths.
The country currently has 6,658 active cases of infection, according to the latest update from the Ghana Health Service.
Below is the cumulative Cases per Region
(Case Count from Highest to Lowest)
Greater Accra Region – 46,189
Ashanti Region – 14,046
Western Region – 4,742
Eastern Region – 3,525
Central Region – 2,783
Volta Region – 1,559
Bono East Region – 1,081
Upper East Region – 994
Northern Region – 970
Bono Region – 924
Western North Region – 797
Ahafo Region – 660
Upper West Region – 357
Oti Region – 272
North East Region – 79
Savannah Region – 72
Enjoy reading our stories?